MESSINA, SILVIA
 Distribuzione geografica
Continente #
AS - Asia 114
EU - Europa 88
NA - Nord America 31
SA - Sud America 9
OC - Oceania 2
Totale 244
Nazione #
SG - Singapore 43
IT - Italia 34
HK - Hong Kong 30
US - Stati Uniti d'America 28
CN - Cina 19
DE - Germania 14
VN - Vietnam 11
CH - Svizzera 9
BR - Brasile 7
FI - Finlandia 6
RU - Federazione Russa 5
SE - Svezia 5
AT - Austria 4
IN - India 3
JP - Giappone 3
AU - Australia 2
CA - Canada 2
ES - Italia 2
MY - Malesia 2
PL - Polonia 2
RS - Serbia 2
AR - Argentina 1
BE - Belgio 1
FR - Francia 1
HU - Ungheria 1
IL - Israele 1
LT - Lituania 1
MX - Messico 1
NL - Olanda 1
PK - Pakistan 1
TR - Turchia 1
UY - Uruguay 1
Totale 244
Città #
Hong Kong 30
Singapore 14
Nuremberg 10
Shanghai 7
Caldwell 4
Milan 4
Reggio Emilia 4
Falkenstein 3
Helsinki 3
Lappeenranta 3
Ashburn 2
Barcelona 2
Belgrade 2
Bắc Ninh 2
Castellina in Chianti 2
Cercola 2
Da Nang 2
Hanoi 2
Kuala Lumpur 2
Machida 2
New York 2
Parma 2
Porto Alegre 2
Quỳnh Lưu 2
Reston 2
Thái Nguyên 2
Vienna 2
Amsterdam 1
Ancona 1
Arakawa 1
Basel 1
Boardman 1
Brussels 1
Budapest 1
Chennai 1
Conselheiro Lafaiete 1
Decatur 1
Divinópolis 1
Florence 1
Frankfurt am Main 1
Guangzhou 1
Guarabira 1
Handan 1
Hangzhou 1
Jerusalem 1
Lawrence 1
Lấp Vò 1
Mancherial 1
Melbourne 1
Mersin 1
Mexico City 1
Montevideo 1
Montreal 1
Moscow 1
Multan 1
Naples 1
Princeton 1
Sennori 1
St Louis 1
São Luís 1
Taizhou 1
Vimodrone 1
Volta Redonda 1
Warsaw 1
Wroclaw 1
Wuhan 1
Wuxi 1
Xi'an 1
Totale 157
Nome #
Towards imaging criteria that best differentiate MS from NMOSD and MOGAD: Large multi-ethnic population and different clinical scenarios 75
More Than the Sum of Its Parts: Disrupted Core Periphery of Multiplex Brain Networks in Multiple Sclerosis 32
The value of routine blood work-up in clinical stratification and prognosis of patients with amyotrophic lateral sclerosis 28
Diagnostic Performance of Cortical Lesions and the Central Vein Sign in Multiple Sclerosis 26
Clinical and MRI measures to identify non-acute MOG-antibody disease in adults 25
The influence of MOGAD on diagnosis of multiple sclerosis using MRI 24
Correction to: Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 Study (Neurology and Therapy, (2024), 13, 3, (611-624), 10.1007/s40120-024-00591-z) 19
Evaluating the Effectiveness, Tolerability, and Safety of Eptinezumab in High-Frequency and Chronic Migraine in Real World: EMBRACE—The First Italian Multicenter, Prospective, Real-Life Study 14
Identifying cognitive phenotypes in multiple sclerosis using machine learning models: a multicentre study 14
The unfolded protein response in amyotrophic later sclerosis: Results of a phase 2 trial 8
Discriminating MS from MOGAD using deep learning attention maps 6
MRI and clinical features differentiate non-acute MOGAD from AQP4-NMOSD and RRMS: a MAGNIMS multicenter study 6
Totale 277
Categoria #
all - tutte 1.519
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.519


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202221 0 0 0 0 0 0 0 0 0 0 16 5
2022/202330 7 4 1 4 3 4 1 3 0 0 0 3
2023/202434 0 3 1 3 2 3 9 3 5 1 2 2
2024/2025192 9 6 11 15 12 8 19 16 53 43 0 0
Totale 277